These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
761 related articles for article (PubMed ID: 31692053)
1. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling. Zheng S; Li M; Miao K; Xu H J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p. Li S; Zhou J; Wang Z; Wang P; Gao X; Wang Y Biomed Pharmacother; 2018 Aug; 104():451-457. PubMed ID: 29793177 [TBL] [Abstract][Full Text] [Related]
3. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982 [TBL] [Abstract][Full Text] [Related]
4. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy. Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923 [TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis. Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110 [TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
7. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis. Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967 [TBL] [Abstract][Full Text] [Related]
8. LncRNA GAS5 sponges miR-362-5p to promote sensitivity of thyroid cancer cells to Li L; Lin X; Xu P; Jiao Y; Fu P IUBMB Life; 2020 Nov; 72(11):2420-2431. PubMed ID: 32856394 [TBL] [Abstract][Full Text] [Related]
9. lncRNA GAS5 regulates myocardial infarction by targeting the miR-525-5p/CALM2 axis. Zhang Y; Hou YM; Gao F; Xiao JW; Li CC; Tang Y J Cell Biochem; 2019 Nov; 120(11):18678-18688. PubMed ID: 31429119 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological Functions. Filippova EA; Fridman MV; Burdennyy AM; Loginov VI; Pronina IV; Lukina SS; Dmitriev AA; Braga EA Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202777 [TBL] [Abstract][Full Text] [Related]
11. Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells. Li J; Li L; Yuan H; Huang XW; Xiang T; Dai S Cell Cycle; 2019 Aug; 18(16):1965-1975. PubMed ID: 31282278 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p. Gao ZQ; Wang JF; Chen DH; Ma XS; Yang W; Zhe T; Dang XW Biomed Pharmacother; 2018 Jan; 97():809-817. PubMed ID: 29112934 [TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis. Liu X; Song J; Kang Y; Wang Y; Chen A J Cell Biochem; 2020 Nov; 121(11):4601-4611. PubMed ID: 32277517 [TBL] [Abstract][Full Text] [Related]
14. Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5. Zhao H; Yu H; Zheng J; Ning N; Tang F; Yang Y; Wang Y Gynecol Oncol; 2018 Nov; 151(2):345-355. PubMed ID: 30201235 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of glioma. Jin C; Zhao J; Zhang ZP; Wu M; Li J; Xiao GL; Liu B; Liao YX; Liu JP J Neurooncol; 2020 Jul; 148(3):529-543. PubMed ID: 32472311 [TBL] [Abstract][Full Text] [Related]
16. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169 [TBL] [Abstract][Full Text] [Related]
17. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer. Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449 [TBL] [Abstract][Full Text] [Related]
18. LncRNA OTUD6B-AS1 promotes paclitaxel resistance in triple negative breast cancer by regulation of miR-26a-5p/MTDH pathway-mediated autophagy and genomic instability. Li PP; Li RG; Huang YQ; Lu JP; Zhang WJ; Wang ZY Aging (Albany NY); 2021 Nov; 13(21):24171-24191. PubMed ID: 34740994 [TBL] [Abstract][Full Text] [Related]
19. LncRNA growth arrest-specific transcript 5 targets miR-21 gene and regulates bladder cancer cell proliferation and apoptosis through PTEN. Chen D; Guo Y; Chen Y; Guo Q; Chen J; Li Y; Zheng Q; Jiang M; Xi M; Cheng L Cancer Med; 2020 Apr; 9(8):2846-2858. PubMed ID: 32069387 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway. Qiao Y; Wang B; Yan Y; Niu L Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]